Tag Archives: (VRTX)

Biotech Letter

The Gene Editing Tollbooth

Posted on by april@madhedgefundtrader.com

Did you know that the first successful gene therapy was approved by the FDA just 33 years ago, back in 1990? While most of us were arguing about whether compact discs would replace cassette tapes, some wild-eyed scientists were literally rewriting human DNA. Talk about thinking ahead. Fast forward to today, and we’ve got Vertex […]

Continue reading →
Biotech Letter

Press 1 For English, Press 2 For Robot Surgery

Posted on by april@madhedgefundtrader.com

Let me set the scene. You’re stuck in a doctor’s waiting room that still smells like the Clinton administration, flipping through a Time magazine featuring the rise of the iPhone 6 (because apparently time stopped in medical offices). Then a robot wheels by carrying a tray of someone else’s blood samples. Your doctor, meanwhile, is […]

Continue reading →
Biotech Letter

The Biotech That Figured Out How To Make Oxygen Profitable

Posted on by april@madhedgefundtrader.com

A few months ago, I was catching up with a former colleague over coffee when he casually mentioned something that nearly made me spit out my latte. “You know this little pill I take twice a day?” he said, tapping his chest. “It probably costs more than most people’s rent. Maybe their mortgage too.” He […]

Continue reading →
Biotech Letter

Healthcare’s Falling Knife

Posted on by april@madhedgefundtrader.com

While driving back from my nephew’s soccer game last weekend, I needed to pick up a prescription at my local pharmacy. The line was moving at glacial speed, so I struck up a conversation with the woman in front of me, who mentioned she worked as a nurse at a UnitedHealth-affiliated clinic. “Our patients are […]

Continue reading →